1. Pharmacodynamics, pharmacokinetics and safety of revefenacin (TD-4208), a long-acting muscarinic antagonist, in patients with chronic obstructive pulmonary disease (COPD): Results of two randomized, double-blind, phase 2 studies. (February 2018) Authors: Quinn, Dean; Barnes, Christopher N.; Yates, Wayne; Bourdet, David L.; Moran, Edmund J.; Potgieter, Peter; Nicholls, Andrew; Haumann, Brett; Singh, Dave Journal: Pulmonary pharmacology & therapeutics Issue: Volume 48(2018) Page Start: 71 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗